|
K-RAS is one of the mutations commonly encountered in colorectal cancer tissue. 85% of cases of colorectal cancer are caused by mutations in the sporadic K-RAS genes. One of the metastasis therapy of colorectal cancer is the monoclonal antibody used to target the EGFR (Epidermal Growth Factor Receptor) gene. Where the therapy showed a positive response to patients who did not have mutations in the genes K-RAS
Link Full Text:
https://mega.nz/#!2p8zmSCI!bfoMY_QVpZ6_cPCSv5Fk08CWZq4WFuR3rkq5zrjtPMY Website:
http://bedahfkuns-elearning.com/learning-system/mod/forum/discuss.php?d=199
Nama : Saqib Nahdi, dr Judul :Sebaran Ekspresi Gen KRAS pada Metasis Kanke Kolorektal Periode Januari - Desember 2016 du RSUD Dr. Moewardi Pembimbing : Dr. Ida Bagus Budhi Surya Adnyana, dr, SpBKBD, Mkes
Pada Hari/Tanggal : Jumat, 14 Juli 2017 Jam : 06.30 WIB Tempat : Ruang Pertemuan Bedah Anggrek IV
Penaya wajib 1. Rakhman W, dr
2. Muh Singgih, dr
3. Fanny Indra Warman, dr |